Home › Studies › PRJNA1246224
PRJNA1246224 SRP576364

Gut metagenomes in MASLD vs controls, female nurses, USA

MASLD-A multi-omic study of microbiome and metabolic dysfunction-associated steatotic liver disease (human)

713 stool samples from a case-control study of women (Nurses' Health Study II) comparing metabolic dysfunction-associated steatotic liver disease (MASLD) cases to matched healthy controls, sampled in Utah, USA. machine-written summary

713 samples · 713 runs · US · Adult · 2025 · 3.96 Gbp / sample

Sources
✓Sequence archive 3,565✓Abstract / description 713✓Full text 713○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive3,565 sample values (collection date, country, latitude, location region, longitude)
✓ Abstract / description713 sample values (subject id)
✓ Full text713 sample values (sex) · PMC12320953, PMC13275893
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult713
Sex
female713
Country
US713
Body site
primary713
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 1 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 6 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 168 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 538 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 3.96 Gbp per sample0130Gbp
Community composition
Blautia_A 9.0%Bacteroides 6.8%Faecalibacterium 6.6%Roseburia 5.3%Alistipes 4.9%Phocaeicola 3.3%Bifidobacterium 2.6%Ruminococcoides 2.3%Mediterraneibacter 2.3%Streptococcus 2.3%Collinsella 2.1%Fusicatenibacter 1.9%not assigned to a genus 7.1%other genera 43.4%

Genera, mean relative abundance over 702 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category713 100%
country713 100%713
health_condition0 0%
subject_id713 100%713
collection_date713 100%713
detailed_location713 100%
latitude713 100%713
location_region713 100%713
longitude713 100%713
sex713 100%713
Papers (2)
  • Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease. 2025 PMID 40604156 PMC12320953 own_data
  • Multi-kingdom profiling reveals altered gut phage-bacteria-metabolite interactions in MASLD. 2026 PMID 42000726 PMC13275893 unsure
Details
Archive description

Leveraging a large-scale collection of stool specimens in the Micro-N study within the prospective cohort study (Nurses' Health Study II), we performed shotgun metagenomic sequencing and untargeted metabolomics profiling among 211 women with metabolic dysfunction-associated steatotic liver disease (MASLD), matched to age-, body mass index-, and location-matched healthy controls (total N with matched and unmatched controls=713). We found microbiome and metabolomic profiles to be altered in MASLD cases compared to controls. Data deposited include metagenomic sequencing data (after removing the human sequences) and metabolomics data.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.70. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site study.description · “large-scale collection of stool specimens in the Micro-N study”
  • life stage study.description · “211 women with metabolic dysfunction-associated steatotic liver disease”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN47769379collection_date2022-04-12R10.90biosample.attribute:collection_date2022-04-12
SAMN47769379countryUSR10.90sample.attr.geo_loc_nameUSA:Utah
SAMN47769379latitude40.7600R10.90biosample.attribute:lat_lon40.76 N 111.89 W
SAMN47769379location_regionUtahR10.85biosample.attribute:geo_loc_nameUSA:Utah
SAMN47769379longitude-111.8900R10.90biosample.attribute:lat_lon40.76 N 111.89 W
SAMN47769379sexfemaleR30.70paper.fulltext.methodsincludes 116,429 female nurses aged 25–42 years
SAMN47769379subject_idSAMN47769379R40.60design.one_sample_per_subject:abstract211 MASLD cases and 502 controls from a cohort of female nurses
Sequencing

713 runs over 713 samples · mean 4.03 Gbp per run (median 3.96 Gbp, total 2,873.73 Gbp; 713 runs with a base count) · layout SINGLE 713 · platform ILLUMINA 713 · models Illumina HiSeq 4000 (713) · 98% of runs with a Sandpiper profile · first public 2025-04-05

Authors (34)

Kim H first · Nelson P · Nzabarushimana E · Shen J · Jensen J · Bhosle A · Li C · Lee N · Everett C · Berdy B · Frongillo G · Livny J · Hu FB · Simon TG · McIver L · Franzosa EA · Chan AT · Hayete B · Thompson KN · Huttenhower C · Nguyen LH last · Zhou X first · Zhou D · Pu Y · Sun Z · Qi W · Jin J · Zhang W · Xia M · Wang C · Hong S · Jiao N · Zheng Y · Liu T last

Downloads

PRJNA1246224.csv.gz (17.9 KB) · parquet (99.5 KB) — all 713 samples, every field with route and confidence · PRJNA1246224_determinations.csv.gz (28.8 KB) — 4,991 evidence rows

Samples (713 · every field this project has values for · hover a cell for its source)
Loading the sample table…